SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    L. Leenhardt, P. Grosclaude, Épidémiologie et facteurs de risque des cancers thyroïdiens, Médecine Nucléaire, 2012, 36, 1, 3

    CrossRef

  2. 2
    S. W. Park, M. K. Kim, K. H. Kwon, J. Kim, Association between a promoter polymorphism (rs2192752, –1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population, International Journal of Immunogenetics, 2012, 39, 3
  3. 3
    Li Xu, Phi C. Doan, Qingyi Wei, Yanhong Liu, Guojun Li, Erich M. Sturgis, Association ofBRCA1Functional Single Nucleotide Polymorphisms with Risk of Differentiated Thyroid Carcinoma, Thyroid, 2012, 22, 1, 35

    CrossRef

  4. You have free access to this content4
    Edgar P. Simard, Elizabeth M. Ward, Rebecca Siegel, Ahmedin Jemal, Cancers with increasing incidence trends in the United States: 1999 through 2008, CA: A Cancer Journal for Clinicians, 2012, 62, 2
  5. 5
    Irene Isabel Payad Lim, Tsivia Hochman, Sheila Nafula Blumberg, Kepal Narendra Patel, Keith Stuart Heller, Jennifer Braemar Ogilvie, Disparities in the Initial Presentation of Differentiated Thyroid Cancer in a Large Public Hospital and Adjoining University Teaching Hospital, Thyroid, 2012, 22, 3, 269

    CrossRef

  6. 6
    Gudrun Leidig-Bruckner, Gerd Cichorowski, Peter Sattler, Thomas Bruckner, Bernd Sattler, Evaluation of thyroid nodules – combined use of 99mTc-methylisobutylnitrile scintigraphy and aspiration cytology to assess risk of malignancy and stratify patients for surgical or nonsurgical therapy – a retrospective cohort study, Clinical Endocrinology, 2012, 76, 5
  7. 7
    Li Xu, Guojun Li, Qingyi Wei, Adel K. El-Naggar, Erich M. Sturgis, Family history of cancer and risk of sporadic differentiated thyroid carcinoma, Cancer, 2012, 118, 5
  8. 8
    Ji-Hun Mo, Ik J. Choi, Woo-Jin Jeong, Eun-Hui Jeon, Soon-Hyun Ahn, HIF-1α and HSP90: Target molecules selected from a tumorigenic papillary thyroid carcinoma cell line, Cancer Science, 2012, 103, 3
  9. 9
    Ernest L. Mazzaferri, Managing Thyroid Microcarcinomas, Yonsei Medical Journal, 2012, 53, 1, 1

    CrossRef

  10. 10
    Pamela L. Horn-Ross, Ellen T. Chang, Christina A. Clarke, Theresa H. M. Keegan, Rudolph P. Rull, Thu Quach, Scarlett Lin Gomez, Nativity and papillary thyroid cancer incidence rates among Hispanic women in California, Cancer, 2012, 118, 1
  11. 11
    Bong-Keun Choe, Su Kang Kim, Hae Jeong Park, Hyun-Kyung Park, Kee Hwan Kwon, Sung Hoon Lim, Sung-Vin Yim, Polymorphisms of TGFBR2 contribute to the progression of papillary thyroid carcinoma, Molecular & Cellular Toxicology, 2012, 8, 1, 1

    CrossRef

  12. 12
    Clare Kahn, Leonardo Simonella, Mark Sywak, Steven Boyages, Owen Ung, Dianne O'Connell, Postsurgical Pathology Reporting of Thyroid Cancer in New South Wales, Australia, Thyroid, 2012, 120423121150004

    CrossRef

  13. 13
    Marci J. Neidich, David L. Steward, Safety and feasibility of elective minimally invasive video-assisted central neck dissection for thyroid carcinoma, Head & Neck, 2012, 34, 3
  14. 14
    Risa L. Wong, Hadiza S. Kazaure, Sanziana A. Roman, Julie A. Sosa, Simultaneous Medullary and Differentiated Thyroid Cancer: A Population-Level Analysis of an Increasingly Common Entity, Annals of Surgical Oncology, 2012,

    CrossRef

  15. 15
    Tae Hyuk Kim, Young Joo Park, Jung Ah Lim, Hwa Young Ahn, Eun Kyung Lee, You Jin Lee, Kyung Won Kim, Seo Kyung Hahn, Yeo Kyu Youn, Kwang Hyun Kim, Bo Youn Cho, Do Joon Park, The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer, Cancer, 2012, 118, 7
  16. 16
    James E. Wiseman, Philip H.G. Ituarte, Kevin Ro, Jesse D. Pasternak, Chi A. Quach, Areti K. Tillou, O. Joe Hines, Jonathan R. Hiatt, Michael W. Yeh, The effect of a dedicated endocrine surgery program on general surgery training: a single institutional experience, The American Journal of Surgery, 2012, 203, 6, 782

    CrossRef

  17. 17
    J. Jendrzejewski, H. He, H. S. Radomska, W. Li, J. Tomsic, S. Liyanarachchi, R. V. Davuluri, R. Nagy, A. de la Chapelle, The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type, Proceedings of the National Academy of Sciences, 2012, 109, 22, 8646

    CrossRef

  18. 18
    Graziano Ceresini, Luigi Corcione, Maria Michiara, Paolo Sgargi, Giulio Teresi, Annalisa Gilli, Elisa Usberti, Enrico Silini, Gian Paolo Ceda, Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009, Cancer, 2012, 118, 11
  19. 19
    Iain J. Nixon, Ian Ganly, Snehal G. Patel, Frank L. Palmer, Monica M. Whitcher, Robert M. Tuttle, Ashok Shaha, Jatin P. Shah, Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy, Surgery, 2012, 151, 4, 571

    CrossRef

  20. 20
    Chung-Che Charles Wang, Lyssa Friedman, Giulia C. Kennedy, Hui Wang, Electron Kebebew, David L. Steward, Martha A. Zeiger, William H. Westra, Yongchun Wang, Elham Khanafshar, Giovanni Fellegara, Juan Rosai, Virginia LiVolsi, Richard B. Lanman, A Large Multicenter Correlation Study of Thyroid Nodule Cytopathology and Histopathology, Thyroid, 2011, 21, 3, 243

    CrossRef

  21. 21
    Su Kang Kim, Dong Kwan Kim, In-Hwan Oh, Jeong Yoon Song, Kee Hwan Kwon, Bong-Keun Choe, Yong Ho Kim, A missense polymorphism (rs11895564, Ala380Thr) of integrin alpha 6 is associated with the development and progression of papillary thyroid carcinoma in Korean population, Journal of the Korean Surgical Society, 2011, 81, 5, 308

    CrossRef

  22. 22
    Young Gyu Eun, Il Ki Hong, Su Kang Kim, Hyun-Kyung Park, Sam Kwon, Dae Han Chung, Kee Hwan Kwon, A Polymorphism (rs1801018, Thr7Thr) of BCL2 is Associated with Papillary Thyroid Cancer in Korean Population, Clinical and Experimental Otorhinolaryngology, 2011, 4, 3, 149

    CrossRef

  23. 23
    L. Leenhardt, P. Grosclaude, Épidémiologie des cancers thyroïdiens dans le monde, Annales d'Endocrinologie, 2011, 72, 2, 136

    CrossRef

  24. 24
    I. Landa, M. Robledo, Association studies in thyroid cancer susceptibility: are we on the right track?, Journal of Molecular Endocrinology, 2011, 47, 1, R43

    CrossRef

  25. 25
    Oliver Gimm, Maria Domenica Castellone, Cuong Hoang-Vu, Electron Kebebew, Biomarkers in Thyroid Tumor Research: New Diagnostic Tools and Potential Targets of Molecular-Based Therapy, Journal of Thyroid Research, 2011, 2011, 1

    CrossRef

  26. 26
    Marisa Cañadas Garre, Martín López de la Torre Casares, Patricia Becerra Massare, Miguel Ángel López Nevot, Jesús Villar Del Moral, Nuria Muñoz Pérez, Ricardo Vílchez Joya, Rosa Montes Ramírez, José Manuel Llamas Elvira, BRAFT1799A mutation in the primary tumor as a marker of risk, recurrence, or persistence of papillary thyroid carcinoma, Endocrinología y Nutrición (English Edition), 2011, 58, 4, 175

    CrossRef

  27. 27
    L. L. Cunha, R. C. Ferreira, M. A. Marcello, J. Vassallo, L. S. Ward, Clinical and Pathological Implications of Concurrent Autoimmune Thyroid Disorders and Papillary Thyroid Cancer, Journal of Thyroid Research, 2011, 2011, 1

    CrossRef

  28. 28
    Jong-Ryool Oh, Byung-Hyun Byun, Sun-Pyo Hong, Ari Chong, Jahae Kim, Su-Woong Yoo, Sae-Ryung Kang, Dong-Yeon Kim, Ho-Chun Song, Hee-Seung Bom, Jung-Joon Min, Comparison of 131I whole-body imaging, 131I SPECT/CT, and 18F-FDG PET/CT in the detection of metastatic thyroid cancer, European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38, 8, 1459

    CrossRef

  29. 29
    Hee Kyung Kim, Soo Youn Lee, Ji In Lee, Hye Won Jang, Soo Kyoung Kim, Hye Soo Chung, Alice Hyun Kyung Tan, Kyu Yeon Hur, Jae Hyeon Kim, Jae Hoon Chung, Sun Wook Kim, Daily urine iodine excretion while consuming a low-iodine diet in preparation for radioactive iodine therapy in a high iodine intake area, Clinical Endocrinology, 2011, 75, 6
  30. 30
    Pamela Jo Harris, Keith C Bible, Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches, Expert Opinion on Investigational Drugs, 2011, 20, 10, 1357

    CrossRef

  31. 31
    Tracy S. Wang, Endocrine surgery, The American Journal of Surgery, 2011, 202, 3, 369

    CrossRef

  32. 32
    Aarti Mathur, Willeford Moses, Reza Rahbari, Elham Khanafshar, Quan-Yang Duh, Orlo Clark, Electron Kebebew, Higher rate of BRAF mutation in papillary thyroid cancer over time, Cancer, 2011, 117, 19
  33. 33
    Ileana Gabriela Sanchez Rubio, Ana Luiza Galrão, Marco Aurelio Santo, Antonio Carlos Zanini, Geraldo Medeiros-Neto, Levothyroxine Absorption in Morbidly Obese Patients Before and After Roux-En-Y Gastric Bypass (RYGB) Surgery, Obesity Surgery, 2011, 22, 2, 253

    CrossRef

  34. 34
    S.J. Schonfeld, C. Lee, A. Berrington de González, Medical Exposure to Radiation and Thyroid Cancer, Clinical Oncology, 2011, 23, 4, 244

    CrossRef

  35. 35
    Maura Di Vito, Elena De Santis, Giulietta Anna Perrone, Emanuela Mari, Maria Chiara Giordano, Enrico De Antoni, Luigi Coppola, Guido Fadda, Marco Tafani, Angelo Carpi, Matteo A. Russo, Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser-capture microdissection and molecular biology, Cancer Science, 2011, 102, 10
  36. 36
    Clare Kahn, Leonardo Simonella, Mark Sywak, Steven Boyages, Owen Ung, Dianne O’Connell, Pathways to the diagnosis of thyroid cancer in New South Wales: a population-based cross-sectional study, Cancer Causes & Control, 2011, 23, 1, 35

    CrossRef

  37. 37
    Marisa Cañadas Garre, Martín López de la Torre Casares, Patricia Becerra Massare, Miguel Ángel López Nevot, Jesús Villar Del Moral, Nuria Muñoz Pérez, Ricardo Vílchez Joya, Rosa Montes Ramírez, José Manuel Llamas Elvira, Presencia de la mutación BRAFT1799A en el tumor primario como indicador de riesgo, recidiva o persistencia de carcinoma papilar de tiroides, Endocrinología y Nutrición, 2011, 58, 4, 175

    CrossRef

  38. 38
    Christoph Reiners, Heribert Hänscheid, Markus Luster, Michael Lassmann, Frederik A. Verburg, Radioiodine for remnant ablation and therapy of metastatic disease, Nature Reviews Endocrinology, 2011, 7, 10, 589

    CrossRef

  39. 39
    Libo Chen, Yan Shen, Quanyong Luo, Yongli Yu, Hankui Lu, Ruisen Zhu, Response to Sorafenib at a Low Dose in Patients with Radioiodine-Refractory Pulmonary Metastases from Papillary Thyroid Carcinoma, Thyroid, 2011, 21, 2, 119

    CrossRef

  40. 40
    Seyed Mohsen Mousavi, Andreas Brandt, Jan Sundquist, Kari Hemminki, Risks of papillary and follicular thyroid cancer among immigrants to Sweden, International Journal of Cancer, 2011, 129, 9
  41. 41
    Andreas Machens, Henning Dralle, Simultaneous Medullary and Papillary Thyroid Cancer: A Novel Entity?, Annals of Surgical Oncology, 2011, 19, 1, 37

    CrossRef

  42. 42
    Yongchun Wang, Alan K. Meeker, Jeanne Kowalski, Hua-Ling Tsai, Helina Somervell, Christopher Heaphy, Lauren E. Sangenario, Nijaguna Prasad, William H. Westra, Martha A. Zeiger, Christopher B. Umbricht, Telomere Length Is Related to Alternative Splice Patterns of Telomerase in Thyroid Tumors, The American Journal of Pathology, 2011, 179, 3, 1415

    CrossRef

  43. 43
    David T. Hughes, Megan R. Haymart, Barbra S. Miller, Paul G. Gauger, Gerard M. Doherty, The Most Commonly Occurring Papillary Thyroid Cancer in the United States Is Now a Microcarcinoma in a Patient Older than 45 Years, Thyroid, 2011, 21, 3, 231

    CrossRef

  44. 44
    Elham Khanafshar, Ricardo V. Lloyd, The Spectrum of Papillary Thyroid Carcinoma Variants, Advances in Anatomic Pathology, 2011, 18, 1, 90

    CrossRef

  45. 45
    Natalya Rukhman, Alan Silverberg, Thyroid cancer in older men, The Aging Male, 2011, 14, 2, 91

    CrossRef

  46. 46
    Laura E. Soloway, Francis P. Boscoe, Maria J. Schymura, Amy R. Kahn, Aura L. Weinstein, Baozhen Qiao, Colleen C. McLaughlin, Thyroid Cancer Incidence in Highly Observant Jewish Neighborhoods in Metropolitan New York City, Thyroid, 2011, 21, 11, 1255

    CrossRef

  47. 47
    Lisa M. Roche, Xiaoling Niu, Karen S. Pawlish, Kevin A. Henry, Thyroid Cancer Incidence in New Jersey: Time Trend, Birth Cohort and Socioeconomic Status Analysis (1979–2006), Journal of Environmental and Public Health, 2011, 2011, 1

    CrossRef

  48. 48
    Anthony Po Wing Yuen, Ambrose Chung Wai Ho, Birgitta Yee Hang Wong, Ultrasonographic screening for occult thyroid cancer, Head & Neck, 2011, 33, 4
  49. 49
    Christopher R. McHenry, Judy Jin, Current Surgical Therapy, 2011,

    CrossRef

  50. 50
    John D. Cramer, Pingfu Fu, Karem C. Harth, Seunghee Margevicius, Scott M. Wilhelm, Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry, Surgery, 2010, 148, 6, 1147

    CrossRef

  51. 51
    R.C. Smallridge, J.A. Copland, Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies, Clinical Oncology, 2010, 22, 6, 486

    CrossRef

  52. 52
    Bernadette Biondi, David S. Cooper, Benefits of Thyrotropin Suppression Versus the Risks of Adverse Effects in Differentiated Thyroid Cancer, Thyroid, 2010, 20, 2, 135

    CrossRef

  53. 53
    Shih-Ping Cheng, Chin-Wen Chi, Chi-Yuan Tzen, Tsen-Long Yang, Jie-Jen Lee, Tsang-Pai Liu, Chien-Liang Liu, Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma, Surgery, 2010, 147, 6, 847

    CrossRef

  54. 54
    Shaun R. Brown, Sukhyung Lee, Tommy A. Brown, Brad E. Waddell, Effect of race on thyroid cancer care in an equal access healthcare system, The American Journal of Surgery, 2010, 199, 5, 685

    CrossRef

  55. 55
    Keith C Bible, Vera J Suman, Julian R Molina, Robert C Smallridge, William J Maples, Michael E Menefee, Joseph Rubin, Kostandinos Sideras, John C Morris, Bryan McIver, Jill K Burton, Kevin P Webster, Carolyn Bieber, Anne M Traynor, Patrick J Flynn, Boon Cher Goh, Hui Tang, Susan Percy Ivy, Charles Erlichman, Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study, The Lancet Oncology, 2010, 11, 10, 962

    CrossRef

  56. 56
    Hyunsuk Suh, Ousama A’amar, Eladio Rodriguez-Diaz, Stephanie Lee, Irving Bigio, Jennifer E. Rosen, Elastic Light-Scattering Spectroscopy for Discrimination of Benign from Malignant Disease in Thyroid Nodules, Annals of Surgical Oncology, 2010, 18, 5, 1300

    CrossRef

  57. 57
    Luc G.T. Morris, David Myssiorek, Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis, The American Journal of Surgery, 2010, 200, 4, 454

    CrossRef

  58. 58
    Oladejo Olaleye, Udeme Ekrikpo, Ram Moorthy, Owen Lyne, Jill Wiseberg, Myles Black, David Mitchell, Increasing incidence of differentiated thyroid cancer in South East England: 1987–2006, European Archives of Oto-Rhino-Laryngology, 2010, 268, 6, 899

    CrossRef

  59. 59
    Elizabeth M Ward, Ahmedin Jemal, Amy Chen, Increasing incidence of thyroid cancer: is diagnostic scrutiny the sole explanation?, Future Oncology, 2010, 6, 2, 185

    CrossRef

  60. 60
    Yuri E. Nikiforov, Is ionizing radiation responsible for the increasing incidence of thyroid cancer?, Cancer, 2010, 116, 7
  61. 61
    Shilpi Rajoria, Robert Suriano, Arulkumaran Shanmugam, Yushan Lisa Wilson, Stimson P. Schantz, Jan Geliebter, Raj K. Tiwari, Metastatic Phenotype Is Regulated by Estrogen in Thyroid Cells, Thyroid, 2010, 20, 1, 33

    CrossRef

  62. 62
    Iain J. Nixon, Ian Ganly, Lucy E. Hann, Oscar Lin, Changhong Yu, Suzanne Brandt, Jatin P. Shah, Ashok Shaha, Michael W. Kattan, Snehal G. Patel, Nomogram for predicting malignancy in thyroid nodules using clinical, biochemical, ultrasonographic, and cytologic features, Surgery, 2010, 148, 6, 1120

    CrossRef

  63. 63
    Stephanie Aleskow Stein, Leonard Wartofsky, Screening for thyroid disease: defining high-risk populations, Expert Review of Endocrinology & Metabolism, 2010, 5, 5, 663

    CrossRef

  64. 64
    Carole Spencer, Shireen Fatemi, Peter Singer, John Nicoloff, Jonathan LoPresti, Serum Basal Thyroglobulin Measured by a Second-Generation Assay Correlates with the Recombinant Human Thyrotropin–Stimulated Thyroglobulin Response in Patients Treated for Differentiated Thyroid Cancer, Thyroid, 2010, 20, 6, 587

    CrossRef

  65. 65
    Randall P. Owen, Katherine J. Chou, Carl E. Silver, Yaakov Beilin, Jian J. Tang, Robert T. Yanagisawa, Alessandra Rinaldo, Ashok R. Shaha, Alfio Ferlito, Thyroid and parathyroid surgery in pregnancy, European Archives of Oto-Rhino-Laryngology, 2010, 267, 12, 1825

    CrossRef

  66. 66
    J.A. Sipos, E.L. Mazzaferri, Thyroid Cancer Epidemiology and Prognostic Variables, Clinical Oncology, 2010, 22, 6, 395

    CrossRef

  67. 67
    Reza Rahbari, Lisa Zhang, Electron Kebebew, Thyroid cancer gender disparity, Future Oncology, 2010, 6, 11, 1771

    CrossRef

  68. 68
    (Michael) Jacob Adams, Roy E. Shore, Ann Dozier, Steven E. Lipshultz, Ronald G. Schwartz, Louis S. Constine, Thomas A. Pearson, Marilyn Stovall, Kelly Thevenet-Morrison, Susan G. Fisher, Thyroid Cancer Risk 40+ Years after Irradiation for an Enlarged Thymus: An Update of the Hempelmann Cohort, Radiation Research, 2010, 174, 6a, 753

    CrossRef

  69. 69
    Francesca Giusti, Alberto Falchetti, Francesco Franceschelli, Francesca Marini, Annalisa Tanini, Maria Luisa Brandi, Thyroid Cancer: Current Molecular Perspectives, Journal of Oncology, 2010, 2010, 1

    CrossRef

  70. 70
    F. Pacini, M. G. Castagna, L. Brilli, G. Pentheroudakis, Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, 2010, 21, Supplement 5, v214

    CrossRef

  71. 71
    Leonard Wartofsky, Highlights of the American Thyroid Association Guidelines for Patients with Thyroid Nodules or Differentiated Thyroid Carcinoma: The 2009 Revision, Thyroid, 2009, 19, 11, 1139

    CrossRef

  72. 72
    Erich M. Sturgis, Guojun Li, Molecular Epidemiology of Papillary Thyroid Cancer: In Search of Common Genetic Associations, Thyroid, 2009, 19, 10, 1031

    CrossRef

  73. 73
    G. Pellegriti, F. De Vathaire, C. Scollo, M. Attard, C. Giordano, S. Arena, G. Dardanoni, F. Frasca, P. Malandrino, F. Vermiglio, D. M. Previtera, G. D'Azzo, F. Trimarchi, R. Vigneri, Papillary Thyroid Cancer Incidence in the Volcanic Area of Sicily, JNCI Journal of the National Cancer Institute, 2009, 101, 22, 1575

    CrossRef